近日,由中国食品药品企业质量安全促进会指导,同写意主办的“T20+大会”在苏州召开,大会聚焦新药研发全链条创新,破解产业升级关键命题。国内AI医疗头部企业医渡科技(2158.HK)携智能临床研究一体化解决方案亮相大会,系统呈现了AI驱动临床研究效率提升的可复制路径。AI破解临床研究效率瓶颈一款新药从实验室走向临床,要经历方案设计、患者招募、中心启动、数据管理等漫长流程。耗时久、成本高、流程复杂始终...
Source Link近日,由中国食品药品企业质量安全促进会指导,同写意主办的“T20+大会”在苏州召开,大会聚焦新药研发全链条创新,破解产业升级关键命题。国内AI医疗头部企业医渡科技(2158.HK)携智能临床研究一体化解决方案亮相大会,系统呈现了AI驱动临床研究效率提升的可复制路径。AI破解临床研究效率瓶颈一款新药从实验室走向临床,要经历方案设计、患者招募、中心启动、数据管理等漫长流程。耗时久、成本高、流程复杂始终...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.